SAOL THERAPEUTICS INC

SAOL Therapeutics Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in regulatory compliance, product lifecycle management, and formulation adjustments for government healthcare applications. Their work involves the precise modification of drug product listings, including controlled product deletions, which requires deep familiarity with FDA regulatory frameworks, cGMP standards, and DEA scheduling protocols. The company’s technical capabilities center on maintaining the integrity of pharmaceutical supply chains for federal use, ensuring accurate inventory control and regulatory documentation for controlled substances and specialty therapeutics. Their focus on product deletions suggests a niche specialization in managing discontinuations and regulatory updates within institutional pharmaceutical inventories, requiring meticulous coordination with federal formulary systems. The company has delivered services exclusively to the Department of Veterans Affairs, indicating a targeted relationship focused on supporting VA’s pharmaceutical distribution and formulary management infrastructure. This suggests a role in aligning VA’s drug inventory with clinical guidelines and regulatory changes, likely supporting VA pharmacy networks and centralized procurement systems. SAOL Therapeutics operates within NAICS 325412, which encompasses the production of finished pharmaceutical dosage forms such as tablets, capsules, and injectables. Their activity reflects a specialized position in the government pharmaceutical supply chain, where precision in product tracking and regulatory compliance is critical. They are not engaged in drug discovery or large-scale production but rather in the administrative and logistical refinement of approved pharmaceutical products for federal use. As a small business structured as a 2L entity with no federal certifications, SAOL Therapeutics maintains a lean, focused presence in Roswell, Georgia, serving niche requirements within the federal pharmaceutical sector. Their market positioning is defined by regulatory precision rather than manufacturing scale, making them a specialized partner for agencies requiring accurate and compliant pharmaceutical inventory adjustments.